Here is August's dividend summary. Life has been busy as of late and time seems to be flying by a little bit faster in recent weeks than it typically does - no matter - dividends keep rolling in. At the start of the year I thought I just may hit the 5 digit mark for dividend this year - $10,000+, however, it doesn't look like that will happen. The anticipated dividend growth alone would not be sufficient to meet that mark and I knew a decent amount of capital would be needed to get close, but purchases this year have much few and far between compared to previous years. Without further ado, the August dividend summary is presented below which reflects a favorable YoY dividend income change of +28.2%.
As noted above, the majority of YoY gains in dividend income came via the volume side, a pretty consistent story with respect to the PIV portfolio. Both DAL and CVS are new positions added to the portfolio in the last year. The earnings yield on both these stocks remains very attractive and DAL has made some attempts to grow in recent months with the new partnership/investment announced this past week with a South American airline. Meaningful dividend raises from ABT and AXP are seen above, but the relatively impact on the portfolio due to the size of the positions is modest. AXP recently announced a significant buyback authorization that will a very meaningful impact on reducing the volume of outstanding shares and pave the way for further double digit increase in the dividend rate for year to come. If the valuation of AXP continues its decline, I may very well pick some additional shares in the coming months.
Given the rather late timing of this summary, this post will be followed shortly by a separate blog post with the September 2019 dividend summary. Stay tuned!
No comments:
Post a Comment